Committed to growth
EuroChem-2015-Annual-Report-v2
EuroChem-2015-Annual-Report-v2
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Corporate Governance Report<br />
Maintaining strong governance<br />
continued<br />
Appointments and incentives<br />
One of the Board’s main objectives is <strong>to</strong><br />
ensure management continuity. During the<br />
reporting year, a number of key managers<br />
were appointed.<br />
In 2015 a new organizational and<br />
management structure for the Group was<br />
approved. The Group's structure includes<br />
key positions that significantly influence its<br />
business. The Group’s senior managers<br />
are each responsible for the organization<br />
and development of key functions, both<br />
at the corporate level and as managers<br />
of major strategic projects. Regulation of<br />
appointments <strong>to</strong> such positions is subject <strong>to</strong><br />
rigorous control. In 2015, the Board approved<br />
the appointment of the Group’s General<br />
Counsel as Chief Compliance Officer<br />
and oversaw appointments.<br />
The Board paid particular attention<br />
<strong>to</strong> the development of remuneration and<br />
compensation principles for the Group’s<br />
key personnel. The existing compensation<br />
system was established with due regard <strong>to</strong><br />
best global remuneration practices and is<br />
aimed at achieving the Company’s annual<br />
and long-term goals. Local legislative<br />
requirements and other benefits were also<br />
taken and international relocation packages<br />
were developed.<br />
Particular attention was also paid <strong>to</strong> the<br />
process of determining and assessing<br />
annual targets.<br />
Assessment of the Board<br />
In recent years, assessment of the Board has<br />
taken the form of a questionnaire completed<br />
by Board members, followed by a discussion.<br />
In 2015, the Direc<strong>to</strong>rs were asked about the<br />
three Committees’ areas of responsibility,<br />
their satisfaction with the Board’s overall<br />
performance and which matters they<br />
deemed most essential.<br />
Matters discussed included the Company’s<br />
strategy, human resources, management<br />
tasks, corporate governance, the timely<br />
preparation of quality material, the nature<br />
of discussions at Board and Committee<br />
meetings and the Direc<strong>to</strong>rs’ satisfaction<br />
with the Board’s performance and their<br />
own contribution.<br />
Several priorities for the Board’s attention<br />
were identified:<br />
• Management structure/business<br />
process re-engineering;<br />
• Financial moni<strong>to</strong>ring;<br />
• Potash projects;<br />
• Reputation and communication<br />
management; and<br />
• Further development of IT structure and<br />
au<strong>to</strong>mation of business processes.<br />
Corporate governance<br />
In 2015 the General Meeting of Shareholders<br />
approved new versions of the Articles of<br />
Association and Regulations on the<br />
Company’s corporate governance bodies.<br />
To ensure comprehensive performance<br />
of the Board of Direc<strong>to</strong>rs as the Company’s<br />
strategic management body, Regulations<br />
on the Board’s Committees, which establish<br />
the rules regarding formation, functions and<br />
authorities of the Committees, were updated.<br />
Emphasis was made on new approaches<br />
<strong>to</strong> administer the Company’s subsidiaries<br />
<strong>to</strong> enable effective management and control<br />
over the Company’s assets. The Board<br />
updated the list of key Group companies<br />
and established procedures <strong>to</strong> prioritize<br />
and elaborate their material issues.<br />
The following decisions were made<br />
in the reporting year:<br />
• Formation of the Management Board;<br />
• Appointment of the CEO;<br />
• Formation of the Board of Direc<strong>to</strong>rs’<br />
Committees; and<br />
• Implementation of business projects and<br />
execution of transactions of essential value<br />
<strong>to</strong> the Company.<br />
Remuneration of the Board members<br />
Issues concerning Direc<strong>to</strong>rs’ remuneration<br />
are referred <strong>to</strong> the General Meeting of<br />
Shareholders. Remuneration is fixed<br />
and adjusted according <strong>to</strong> Committee<br />
memberships and Chairmanships;<br />
however, as set out in the Board Member<br />
Remuneration Regulations, only nonexecutive<br />
Direc<strong>to</strong>rs are entitled<br />
<strong>to</strong> remuneration.<br />
The <strong>to</strong>tal amount of remuneration paid<br />
<strong>to</strong> Board members for their contribution<br />
in 2015 (April <strong>to</strong> December) amounted <strong>to</strong><br />
US$1.6 million, including US$272 thousand<br />
in compensation for work-related expenses.<br />
2015<br />
US$k<br />
Total remuneration paid<br />
<strong>to</strong> the members of the Board 1,373<br />
Total compensation for<br />
work-related expenses 272<br />
Direc<strong>to</strong>rs and officers liability insurance<br />
(D&O) is provided by the Company.<br />
The Group does not have a long-term<br />
incentive program (s<strong>to</strong>ck options plan).<br />
54 EuroChem Annual Report and Accounts 2015